FridayMar 24, 2023 2:45 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Board-Approved Action to Regain Compliance with NASDAQ Market Requirements

Freight Technologies (NASDAQ: FRGT), a technology company offering its custom-developed Fr8App, has announced a reverse share split. The move is designed to increase the market price per share of the company’s ordinary share, thereby resulting in Freight Technologies regaining compliance with NASDAQ’s minimum bid price requirement and maintaining its NASDAQ Capital Market listing. FRGT board of directors approved the 10:1 reverse split on March 3, 2023; the split will be effective on or around March 24, 2023. According to the announcement, the company’s ordinary shares will continue to trade on NASDAQ under the symbol FRGT but will trade under a new…

Continue Reading

FridayMar 24, 2023 12:33 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Efforts to Boost Commercial Prospects ‘Paying off in Spades’

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator developing and commercializing its patented DehydraTECH(TM) drug delivery technology. Lexaria is continuing and/or initiating discussions with several larger companies in Europe and North America regarding the licensed use of its technology for both consumer and pharmaceutical sectors. “The materialization of such partnerships hinges on a number of must-haves. Firstly, there must be a tangible product that draws larger companies. Secondly, The decision of whether or not to invest, and the scale of any investment, is based on how well the technologies that form the core of a company have been protected.…

Continue Reading

FridayMar 24, 2023 12:18 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) NanoAb Holds Potential to Combat New COVID-19 Variants

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. “BiondVax is seeing convincingly positive outcomes for preventing and arresting disease in COVID patients during an ongoing preclinical in vivo study, even as continually evolving variants are shutting down emergency-use authorization (‘EUA’)-approved avenues of treatment that may no longer be effective… However, BiondVax’s development of a nanosized antibody (‘NanoAb’), that to date has shown neutralization of all relevant Omicron subvariants, is generating excitement as a potential superior prophylactic approach to COVID prevention… At-risk groups, such…

Continue Reading

FridayMar 24, 2023 11:58 am

QualityStocksNewsBreaks – Why Progressive Care Inc. (RXMD) Is ‘One to Watch’

Progressive Care (OTCQB: RXMD) is an organization based in Florida that, through its wholly owned subsidiaries PharmcoRx Pharmacy and ClearMetrX, offers personalized care services and technology to support the managed health care industries. “Progressive Care offers a wide range of innovative solutions to address the dispensing, delivery, dosing and reimbursement of clinically intensive, high-cost drugs. Progressive Care currently operates four pharmacies in Florida, which generate the majority of its revenue,” reads a recent article. “Pharmacy revenue is derived from dispensing medications, third-party administrative services to 340B-covered entities, and medication therapy management (‘MTM’) services. The company also provides customized management, patient…

Continue Reading

FridayMar 24, 2023 11:40 am

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Positioned as Frontrunner in Psychedelic Drugs Market

Silo Pharma (NASDAQ: SILO) is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. “Silo Pharma has distinguished itself amongst peers for its ground-breaking research into conditions such as post-traumatic stress disorder (‘PTSD’), fibromyalgia, Alzheimer’s disease, and other rare neurological disorders. The company has recently entered into a number of studies designed to develop innovative solutions for previously underserved conditions,” a recent article reads. This comes as a recent study found that psychedelic drugs could show promise as a therapeutic alternative in treating drug-resistant depression. “What the study found was that psychedelics were increasingly able to access…

Continue Reading

FridayMar 24, 2023 11:23 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised to Enable Expedited Care for Heart Attack Patients

HeartBeam (NASDAQ: BEAT) is developing the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. “By applying a suite of proprietary algorithms to simplify vector electrocardiography (‘VECG’), the HeartBeam platform will enable patients and their clinicians to determine quickly and easily if symptoms are due to a heart attack so care can be expedited if required. HeartBeam has two patented products in development. HeartBeam AIMI(TM) is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack more accurately. HeartBeam AIMIGo(TM) is the first and only credit-card-sized,…

Continue Reading

FridayMar 24, 2023 10:30 am

Textiles Industry Experience, Commitment to Sustainability Key to Bed & Bath Brand Developer Coyuchi Inc.’s Success

California-based sustainable bed and bath comfort brand Coyuchi Inc. has established its brand not only on the luxury of its products, but the organic sourcing of the textiles it uses Consumers increasingly are scrutinizing the sourcing of their home decor products in search of evidence they are friendly to earth’s climate and responsibly produced Coyuchi’s management team brings experience in corporate function and an enthusiasm for sustainability in the company’s sourcing and partnerships The company launched a Reg A+ investment offering last year that led to a capital raise topping $1 million One significant driver in choosing fabrics for home…

Continue Reading

FridayMar 24, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented DehydraTECH(TM) Drug Delivery Technology Demonstrates Growing List of Potential Applications as Evidenced Through Numerous R&D Programs

DehydraTECH(TM) is suitable for use with a wide range of product formats, including pharmaceuticals, nutraceuticals, and over-the-counter capsules, pills, tablets, topicals, oral suspensions and more The patented technology increases the speed of onset, bioavailability, brain absorption, and reduces drug administration costs Lexaria currently has multiple R&D programs – yielding successful results and further opportunities for additional study models Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, is increasing bioavailability and improving the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery with its patented DehydraTECH(TM) technology. DehydraTECH is suitable for use…

Continue Reading

FridayMar 24, 2023 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Hits Key Milestone in Global GBM Clinical Trial with the Enrollment of First Patient in Spain

CNS recently enrolled the first patient in Spain in its ongoing global trial evaluating its lead drug candidate, Berubicin, for the treatment of recurrent glioblastoma multiforme (“GBM”) This milestone is the culmination of years of meticulous planning and execution The enrollment of this first patient follows the opening of 37 clinical trial sites of the 59 sites selected across the United States, Italy, France, Spain and Switzerland CNS Pharmaceuticals (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments with a focus on brain cancer, glioblastoma and neuro-oncology, just enrolled its first patient in Spain, marking…

Continue Reading

ThursdayMar 23, 2023 3:29 pm

QualityStocksNewsBreaks – GeoSolar Technologies Inc.’s SmartGreen(TM) Is a Multi-Pronged Solution to Energy Challenges

GeoSolar Technologies (“GST”), a Colorado-based climate technology company, offers SmartGreen(TM) – a whole-home renewable energy system that can help protect homeowners from price volatility while offering energy independence. “GeoSolar’s innovative technology presents a multi-pronged solution that can insulate homeowners from energy instability caused by subsidies while reducing dependence on fossil fuels. The company’s SmartGreen(TM) leverages renewable energy systems and efficiency improvements to dramatically lower or even eliminate utility bills. Geothermal ground loops and photovoltaic solar panels tap into the energy of the sun and earth to generate enough power to run appliances and vehicles. Integrated air ducts and floor loops…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered